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disease (AD) and Parkinson’s disease (PD), has been dramatically
increasing, particularly in the aging population. However, the currently
available therapies merely alleviate the symptoms of these diseases and
are unable to retard disease progression significantly. Traditional Chinese
medicine (TCM) has been used in clinical practice for thousands of years
for ameliorating symptoms or interfering with the pathogenesis of agingassociated diseases. Modern pharmacological studies have proved that
TCM imparts disease-modifying therapeutic effects against these diseases,
such as protection of neurons, clearance of protein aggregates, and
regulation of neuroinflammation. This review summarizes the evidence
from recent studies on AD and PD therapies regarding the neuroprotective
activities and molecular mechanisms of a series of TCM formulations
comprising herbs and their active ingredients. The findings of this review
support the use of TCM as an alternative source of therapy for the
treatment of neurodegenerative diseases.

1

Introduction

Neurodegenerative diseases are a heterogeneous
series of brain disorders with multifactorial causes,
characterized by neuronal loss and dysfunction
in neurogenesis-mediated neuronal replacement
[1, 2]. Data indicate that the worldwide prevalence
of neurodegenerative diseases, such as Alzheimer’s

disease (AD), Parkinson’s disease (PD), Huntington’s disease, amyotrophic lateral sclerosis,
and multiple system atrophy, is dramatically
increasing owing to an increase in the aging
population. AD is the most common disease
leading to dementia in adulthood. AD is involved
in widespread neurodegeneration throughout the
basal forebrain, cortex, and limbic system caused

Corresponding author: Ken Kin-Lam Yung, E-mail: kklyung@hkbu.edu.hk; Yiwu Dai, E-mail: dddyyywww@163.com

208

by neuronal and synaptic loss and is accompanied by symptoms including olfactory deficits,
memory impairment, and cognitive and functional
deterioration. Specific hallmarks of AD include
neurofibrillary tangles caused by hyperphosphorylated Tau proteins and amyloid plaque
deposition [3]. PD is the second most common
neurodegenerative disease and is the most
common movement disorder [4]. Motor symptoms
of PD such as bradykinesia, rigidity, resting
tremor, and postural instability, predominantly
result from the degeneration of dopaminergic (DA)
neurons in the substantia nigra pars compacta
section of the brain. The neuropathological
hallmark of PD is the accumulation of misfolded
fibrillar alpha-synuclein (α-syn) as intracellular
deposits called Lewy bodies and Lewy neuritis
[5]. Considering the increasing societal burden
on families caring for elderly relatives with these
conditions, carrying out research and developing
powerful neuroprotective and neurorestorative
therapeutic drugs is urgently needed.
The currently available treatment approaches
for neurodegenerative diseases target only a small
subset of the population and merely alleviate
the symptoms of these diseases and fail to retard
disease progression. A few US Food and Drug
Administration (FDA)-approved drugs, such as
donepezil and rivastigmine, reduce the symptoms
and retard the progression of these diseases, but
these are unsafe for long-term treatment [6, 7]; for
example, although L-DOPA treatment ameliorates
the motor symptoms of PD in most patients for
several years, its prolonged use frequently leads
to the development of motor complications, known
as L-DOPA-induced dyskinesia, typified by choreic
or large-amplitude choreo-athetotic movements,
dystonia, and ballism [8]. Furthermore, the use
of currently available drugs for PD can result in
resistance to antibiotics and antimalarials as well
as adverse effects involving the cardiovascular
and endocrine systems [9, 10]. All of these pro-
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blems with the current treatments ultimately lead
to permanent disability or death of patients.
Therefore, the development of new synthetic drugs
or the discovery of natural drugs for treating
neurodegenerative diseases is an urgent and
challenging task in the fields of basic sciences
and clinical medicine.
Traditional Chinese medicine (TCM) is a system
of medical practice including various forms such
as herbal medicine, acupuncture, cupping therapy,
guasha, massage (tuina), bonesetter (die-da),
exercise (qigong), and dietary therapy, which have
been clinically applied in China for about 2000
years. TCM includes products of natural origin,
such as plant-based medicines, animal products,
mineral medicines, and various extracted chemical
and biological products as well as their processed
(Pao Zhi) products [11]. Frequent use of natural
products in China over a long period of time has
demonstrated that TCM exhibits efficacy, with
minimal side effects, and is cost-effective, which
are beneficial properties supporting further
development of the Chinese medicine industry.
TCM is an integral part of the healthcare system
in Chinese culture for more than 2000 years for
the treatment of aging-related diseases and conditions, such as dementia, which is a common
feature of both AD and PD [12]. Because neurodegenerative diseases are complex and have
multifactorial causes, TCM offers the advantage of
targeting multiple sites via a multi-component
approach via the synergistic effects of different
components of a single herb or traditional herbal
formulations [13, 14]. Furthermore, the combination of herbal formulations and other drugs
could optimize their therapeutic efficacy with
minimal toxicity and side effects through interactions of different components [15]. Results from
several recent preclinical and clinical studies have
revealed that natural products exhibited good
therapeutic effects in patients with neurodegenerative diseases. Moreover, a huge potential
Journal of Neurorestoratology
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for developing these compounds into therapeutic
drugs to treat neurodegenerative diseases has
been demonstrated by a great deal of in vitro and
in vivo research [16].
Herein, we review the current trends in TCMbased neuroprotective therapy, with a focus on
the development of a series of potential neuroprotective herbal compounds from both traditional
and modern pharmacological perspectives. The
future implications of using TCM as an alternative
source of novel drugs for neurodegenerative
diseases are also discussed.

2

The neuroprotective effects of TCMs

Herbal formulations are commonly used for
clinical treatments involving TCM because of
the synergistic effects between their various
components. In recent studies, many well-known
TCM decoctions, such as Qingxin Kaiqiao Fang,
Danggui Buxue Tang, Jia-Jian-Di-Huang-Yin-Zi
decoction, and Bushen-Yizhi formula, have shown
efficacy in restoring the memory functions in AD
models and alleviating motor impairment in PD
models (Table 1). Some pharmacological mechanisms underlying the effect of these decoctions
on AD and PD have also been explored, especially
their anti-apoptotic properties and ability to modify
the survival microenvironment. Furthermore,
studies have combined advanced isolation and
analytical technologies to evaluate single herbs
and their respective active ingredients. Some herbs
such as Alpinia oxyphylla, Panax ginseng, Radix
Notoginseng, Rhodiola spp., Psoralea corylifolia, and
Ginkgo biloba have beneficial effects in AD models.
Furthermore, Astragalus membranaceus, Polygonum
multiflorum, Acanthopanax senticosus, Achyranthes
bidentata, Radix Paeoniae Alba, and green tea have
protective effects in PD. Moreover, some herbs
such as Tripterygium wilfordii, Ganoderma lucidum,
Radix Glycyrrhizae, and Acorus tatarinowii exert
neuroprotective effects in AD and PD. Basic
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evidence for the beneficial effects of these
medicines on AD and PD is summarized in
Tables 2 and 3, respectively. Chinese medicine
exerts beneficial effects on neurons and enhances
their survival rate in the microenvironment;
thus, it has significant potential for therapeutic
application against neurodegenerative diseases.

3

Possible neuroprotective mechanisms of
TCMs and herbal extracts

Although AD and PD lesions in distinct brain
areas have different etiologies, accumulating
evidence suggests that they share some cellular
and molecular mechanisms. TCM-based treatments
of these diseases have demonstrated several
similar beneficial effects, such as enhancement
of neurogenesis, increased neurotrophic factor
(NTF) secretion, inhibition of neuroinflammation,
and clearance of abnormal protein aggregates.
3.1

Activation of neuronal regeneration

Loss of progressive neurons is the hallmark of
neurodegeneration. However, different neurodegenerative diseases result in distinct pathological
changes to the neurons that vary for each disease;
for instance, neuronal degeneration in AD is
characterized by a global loss of neurons in the
cerebral cortex and hippocampus; however, in
PD, damage is limited to DA neurons in the
substantia nigra [67]. TCM induces neuronal
regeneration via reversal of neuronal death, which
has been demonstrated in different AD and PD
models; for example, Qingxin Kaiqiao Fang exerts
anti-apoptotic effects in the APP/PS1 mouse
model of AD [17]. Polypeptides isolated from
A. bidentata, and tetrahydroxystilbene glucoside
extracted from P. multiflorum have been shown
to protect DA neurons by inhibiting apoptosis
in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-lesioned PD mice and 6-hydroxydopamine
(6-OHDA)-lesioned PD rats [29]. Extracts from
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Table 1

The effects of TCM formulations on AD and PD.

Formulations

Ailment/model

Pharmacological functions

Target

Reference

Qingxin Kaiqiao Fang AD

Reduces pathological degeneration
and improves learning and memory
functions

Bax/Bcl2, caspase-3, p38, and ERK1/2 [17]
MAPK

Danggui Buxue Tang AD

Protects amyloid beta (Aβ)-induced cell
death of cortical neurons

Bax/Bcl2, cleaved-caspases-3 and -9,
and PARP

PD

Attenuates the loss of DA neurons and
enhances the survival microenvironment

[19]
GDNF, GSH, MDA, GFAP, Iba-1,
Tmem119, claudin-5, occludin, CD31(+),
MMP2, MMP3, MMP9, CCL2, CCL4,
and IL-23

Bushen-Yizhi formula PD

Alleviates motor impairments and DA
neuron degeneration andattenuates
neuroinflammation

TH, Nissl, Iba-1, CD68, GFAP, IL-1β,
IL-6, and TNF-α, NLRP3, ASC,
caspase-1, and pro-IL-1β

[20]

Optimized Yinxieling PD
formula

Ameliorates motor dysfunction and
suppresses neuroinflammation

NO, TNF-α, IL-1β, IL-6, GFAP, Iba-1,
and TH

[21]

PD
Recipe for
nourishing Gan-Shen

Reverses rotenone-induced neuronal
death and increases rotenone exposure
days

TH

[22]

Jia-Jian-Di-HuangYin-Zi decoction

Xiao-Er-An-Shen
decoction

PC12 cells

[18]

Induces neurite outgrowth and inhibits NF68, NF160, NF200, CREB, and ARE [23]
oxidative stress
[24]

Modified Kai-Xin-San PC12 cells

Promotes NGF-induced neuronal
differentiation

NF68, NF160, NF200, Trk-A, CREB,
and ERK1/2

Shaoyao-Gancao Tang Cell model of
tauopathy

Reduces neuroinflammation-associated
tauopathy

NO, TNF-α, IL-1β, IL-6, DsRed, ROS, [25]
TUBB3, Iba1, LDH, Tau, Bcl2, BH3,
caspase-3, caspase-8, and cytochrome c

Kai-Xin-San

Astrocytes

Increases neurotrophic factor synthesis

NGF, BDNF, CREB, and ERK1/2

[26]

Wu-Tou decoction

Microglia

Inhibits microglial activation

TMEM119, TNF-α, and GFP

[27]

Qingxin Kaiqiao Fang contains Radix Rehmanniae, Radix Ophiopogonis, Radix Paeoniae, Herba Dendrobii, Cortex Moutan Radicis,
Poria Cocos, Pericarpium Citri Reticulatae, Rhizoma Anemarrhenae, Rhizoma Acori Tatarinowii, and Sophorae Flavescentis. Danggui
Buxue Tang contains Astragali Radix and Angelicae sinensis. Jia-Jian-Di-Huang-Yin-Zi decoction contains Radix Rehmanniae, Fructus
Corni, Radix Morindae Officinalis, Herba Cistanches, Angelicae Sinensis, Radix Asparagi and Radix Paeoniae Alba. Bushen-Yizhi formula
contains Cnidium monnieri, Panax ginseng, Polygonum multiflorum Thuna., Paeonia suffruticosa Andr., Ligustrum lucidum Ait. and Lycium
barbarum. Optimized Yinxieling formula contains Curcuma zedoaria, Glycyrrhiza uralensis, dark plum fruit, Lithospermum erythrorhizon,
Paeonia lactiflora, Sarcandra glabra, and Rhizoma Smilacis Glabrae. Recipe for nourishing Gan-Shen contains Rehmanniag lutinosa Libosch,
Cistanche deserticola Y.C.Ma, Achyranthes bidentata Bl. and Cornus officinalis. Xiao-Er-An-Shen decoction contains Polygalae Radix, Astragali
Radix, Acori Tatarinowii Rhizoma, Citri Reticulatae Pericarpium, Alpiniae Oxyphyllae Fructus, Aurantii Fructus, Rhizoma Pinelliae,
Rhizoma et Radix Notopterygii, and Radix et Rhizoma Glycyrrhizae. Modified Kai-Xin-San and Kai-Xin-San contain Radix et Rhizoma
Ginseng-Radix Polygalae and Rhizoma Acori Tatarinowii-Poria. Shaoyao-Gancao Tang contains Paeonia lactiflora and Glycyrrhiza uralensis.
Wu-Tou decoction contains Radix Aconiti, Herba Ephedrae, Radix Astragali, Raidix Paeoniae Alba, and Radix Glycytthizae.
ASC, apoptosis-associated speck-like protein containing a CARD; BDNF, brain-derived neurotrophic factor; CCL, C-C motif chemokine
ligand; CREB, cAMP response element binding; ERK, extracellular signal-regulated kinase; GDNF, glial cell line-derived neurotrophic
factor; GFAP, glial fibrillary acidic protein; GSH, glutathione; Iba1, ionized calcium binding adaptor molecule 1; IL, interleukin; LDH,
lactate dehydrogenase; MAPK, mitogen-activated protein kinase; MDA, malondialdehyde; MMP, matrix metalloproteinase; NGF,
nerve growth factor; NLRP3, NOD-, LRR- and pyrin domain-containing protein 3; NO, nitric oxide; PARP, poly ADP-ribose polymerase;
ROS, reactive oxygen species; TH, tyrosine hydroxylase; TMEM119, transmembrane protein 119; TNF-α, tumor necrosis factor α.

A. oxyphylla were observed to produce similar
effects in the Aβ1–42-induced AD rats and lipopolysaccharide (LPS)-induced AD mice [30]. The
anti-apoptotic effect of these extracts was accompanied by the regulation of the mitogen-activated

protein kinase (MAPK) signaling pathway [55].
This pathway comprises extracellular signalregulated kinase (ERK), c-Jun N-terminal kinase
(JNK), and p38 kinase as well as their regulation
of downstream targets, such as those encoding
Journal of Neurorestoratology
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The effects of TCMs and their active ingredients on AD.

Herbs/ingredients

AD model

Pharmacological functions

Target

Reference

Alpinia oxyphylla
Extracts, Nootkatone, LPS-/Aβ1–42-induced Attenuates behavioral cognitive
and Tectochrysin
AD model
disorder, Aβ accumulation,
neuronal degeneration, and
neuroinflammation

[28–32]
SOD, GSH, GSH-Px, MDA, TChE,
Aβ1–42, β-secretase, caspase-3, caspase-8,
caspase-9, IKK-α, IκBα, NF-κB, NLRP3,
p53, Bad, Bax, Bcl-2, Bcl-xl, Iba-1, IL-1β,
IL-6, and p-Tau

Radix Notoginseng
Prevents cognitive impairment,
Caenorhabditis
elegans/SAMP8 mice/ reduces the generation and
increases the degradation of Aβ,
Aβ1-42-injected rats
rescues neuronal loss, and
reverses mitochondrial
membrane potential collapse

Aβ1−42, SOD, GSH-Px, ROS, SKN-1,
[33–36]
β-secretase, APP-Thr668, BACE1,
ADAM10, IDE, LDH, Bax/Bcl-2,
cleaved caspase-3, Cyt C, NMDAR1,
CaMKⅡ, ASK-1, JNK, p38, rCBF, and
GLT-1

SAMP1 and SAMP8
mice/SH-SY5Y
cell/Wistar rats/
Male ICR mice

Ameliorates cognitive function,
alleviates Aβ aggregation,
prevents neuronal apoptosis,
and plays antioxidative and
anti-inflammatory roles

[37–39]
CAP1, CAPZB, TOMM40, DSTN,
PARP, Bax, Aβ, Tau, Glu, Asp, GABA,
Ach, DA, Gly, 5-HT, BDNF, CREB,
miR-873-5p, HMOX1, TNF-α, IL-1β,
IGF-1, iNOS, COX-2, NO, and NOS

Cholesterol-fed
rabbits

Ameliorates behavioral deficits,
restores autonomic nervous
system, attenuates Aβ toxicity,
and enhances neuronal metabolic
activities

Aβ, AChE, MDA, ChAT, SOD, BACE1, [40, 41]
RAGE, LRP-1, TC, LDL-C, IDE, cleaved
caspase-3, NAA, Glu, choline, myoinositol, ROS, and RNS

Aβ1-42-induced AD
rat/3xTg-AD mice/
streptozotocin-inject
ed model

Alleviates learning and memory
deficits in rat AD models, prevents
mitochondrial dysfunction, and
protects hippocampal neurons
from apoptosis

Ach, ChAT, SOD, MDA, p-Tau, p-GSK3β, 42–44
NeuN, TrkB, BDNF, ATP, COX, and
caspase-3

Enhances neurogenesis, alleviates
cognitive deficits, improves
learning and memory function,
and ameliorates neuronal
apoptosis and brain atrophy

BrdU, NeuN, Ki67, SOX2, EdU, FGFR1, [45, 46]
EGFR, ERK, AKT, histone H3, DNMT3A,
DNMT3B, Aβ1-42, Nissl, and Tau

Improves cognitive performance
and inhibits key AD-related
protein targets and AD-like
neurobiochemical changes

BACE-1, GSK-3β, Aβ42, AChE, Tau,
TNF-α, IL-6, IL-1β, and d-ROMs

[47, 48]

Aβ, ROS, AChE, SOD, IGFBP2, Bad,
Extract, licochalcone Aβ-GFP 293/SH-SY5Y Ameliorates Aβ-induced
A and liquiritigenin cells/scopolamine-in aggregation and oxidative stress, Bcl2, Bax, cleaved caspase-3, MDA,
duced CD-1 mice
promotes neurite outgrowth, and BDNF, ERK, and CREB
improves scopolamine-induced
cognitive impairments

[49, 50]

Saponins, Rb1, Rg1,
and fraction
n-butanol

Panax ginseng
Glycoproteins, Rg1,
Rh2, Rg5, Rb1, Rg3,
polysaccharides,
and compound K
Royal jelly
Total royal jelly

Rhodiola spp.
Extract

Ganoderma lucidum
Polysaccharides and SAMP8/APP/PS1
alcohol extracts
transgenic mice
including ganoderic
acid and lucidone A
Psoralea corylifolia
Prenylated compounds and total
prenylflavonoids

SAMP8 mice/
recombinant ADrelated proteins

Radix Glycyrrhizae
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(Continued)
Herbs/ingredients

AD model

Pharmacological functions

Target

Reference

Tripterygium wilfordii
Triptolide and
celastrol

Aβ25–35-induced
Ameliorates behavioral and
PC12 cells, APP/PS1 neuropathological changes and
mice/ IMR-32 cells
attenuates the apoptosis of
neuronal PC12 cells

NF-κB, BACE-1, Aβ, CTFβ, MEK1/2,
ERK, Raf-1, sAPPα, sAPPβ, FL-APP,
CTFα, NEP, IDE, ApoE, NOS2, Iba1,
IκBα, Cdc37, ROS, and LC3Ⅱ

[51–53]

Ginkgo biloba
Extract EGb 761

P301S Tau mutant
transgenic mice

CREB, Tau, Iba-1, S100, p62, LC3Ⅱ/Ⅰ,
Improves cognitive function,
increases autophagic activity and ATG5, Beclin 1, cleaved caspase-3,
degradation of p-Tau, and shifts p38, and GSK-3β
microglial proinflammatory activity
to anti-inflammatory activity

[54]

5-HT, 5-hydroxytryptamine; Aβ, β-amyloid; Ach, acetylcholine; AchE, acetylcholinesterase; ADAM10, A disintegrin and
metalloproteinase domain-containing protein 10; ApoE, apolipoprotein E; ASK-1, apoptosis signal-regulating kinase 1; Asp,
aspartic protease; ATG5, autophagy related 5; BACE1, beta-secretase 1; BrdU, bromodeoxyuridine; CAMKⅡ, Ca2+/calmodulindependent protein kinaseⅡ; CAP 1, cyclase-associated protein 1; CAPZB, capping actin protein of muscle z-line subunit beta;
ChAT, choline acetyltransferase; COX, cyclooxygenase; CTFβ, C-terminal fragment β; Cyt C, cytochrome C; DA, dopaminergic; DNMT,
DNA methyltransferase; d-ROMs, derivatives of reactive oxygen metabolites; DSTN, destrin; EdU, 5-Ethynyl-2´-deoxyuridine;
EGFR, epidermal growth factor receptor; FGFR1, fibroblast growth factor receptor 1; GABA, gamma-aminobutyric acid; GLT-1,
glutamate transporter 1; Glu, glutamate; Gly, glycine; GSH-Px, glutathione peroxidase; GSK-3β, glycogen synthase kinase 3β;
HMOX1, heme oxygenase 1; ICR mice, Institute of Cancer Research mice; IDE, insulin-degrading enzyme; IGFBP2, insulin growth
factor-binding protein 2; IκBα, inhibitor of nuclear factor kappa-B α; IKKα, inhibitor of nuclear factor kappa-B kinase α; IGF-1,
insulin-like growth factor 1; iNOS, inducible nitric oxide synthase; JNK, c-Jun N-terminal kinase; LC3, light chain 3; LDL-C, low
density lipoprotein cholesterol; LRP-1, low density lipoprotein receptor-related protein 1; NEP, neprilysin; NeuN, neuronal nuclei;
NF-κB, nuclear factor κB; NMDAR1, N-methyl-D-aspartate receptor1; NOS, nitric oxide synthase; p-Tau, phosphate Tau; RAGE,
receptor for advanced glycation end products; rCBF, regional cerebral blood flow; RNS, reactive nitrogen species; sAPP, soluble
amyloid precursor protein; SKN-1, skinhead-1; SOD, superoxidase dismutase; SOX2, sry-box 2; TC, total cholesterol; TChE, total
cholinesterase; TOMM40, translocase of outer mitochondrial membrane 40; TrkB, tropomyosin-related kinase B.

Table 3

The effects of TCMs and their active ingredients on PD.

Herbs/ingredients

PD model

Pharmacological functions

Target

Reference

Polygonum multiflorum
Extracts,
tetrahydroxystilbene
glucoside

6-OHDA-induced rat
Attenuates motor disorder,
and SH-SY5Y cells with suppresses neuroinflammation,
MPP+-induced injury
protects DA neurons, and resists
oxidative stress

TH, DA, DOPAC, OX-42, Iba1, [55, 56]
NO, TNF-α, IL-1β, ERK1/2, p38,
GSH, MDA, ROS, JNK, and
caspase-3

Astragalus membranaceus
Astragalosides,
polysaccharides, and
flavonoids

MPTP-induced mice
model andneural
stem cells

Alleviates behavioral impairments
and DA neuron degeneration,
inhibits neuroinflammation,
induces neurogenesis, and
stabilizes mitochondrial
function

TH, Iba1, CD68, SOD, GSH-Px,
glutathione, GSSG, NF-κB,
NLRP3, ASC, caspase-1, proIL-1β, IL-1β, Nrf2, DHE, ROS,
DAT, Nurrl, Ptx3, Shh, RN18s,
Nestin, Tuj-1, BrdU, Bax, Bcl2,
Cyt c, and caspase-3

[57–59]

SH-SY5Y cells and
neuronsexposed
torotenone/6-OHDA

Protects DA neurons from
apoptosis

LDH, Bax, and Bcl2

[60]

MPTP-induced mice

Enhances DA neuron’s survival
and improves motor coordination,
striatal dopamine level, and its
metabolite levels

DA, DOPAC, HVA, DAT, TH,
Bax, Bcl2, α-syn, and CREB

[61]

Achyranthes bidentata
Polypeptides

Radix Paeonia Alba
Total glucosides
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(Continued)
Herbs/ingredients

PD model

Pharmacological functions

Target

Reference

Green tea
Restores impaired movement
behavior and modulates
peripheral immune response

TH, TNF-α, IL-6, CD3, CD4, and [62]
CD8

MPTP-induced mouse

Inhibits mitochondrial
dysfunction

OXPHOS, ROS, ATP, MDA,
Parkin, PINK1, DJ-1, α-syn,
LRRK2, NDUFV2, MT-ND1,
SDHA, and SDHC

MPTP-induced mouse

Improves locomotor performance
and mitochondrial movement
dysfunction and protects against
the loss of DA neurons

TH, ROS, ATP, NIX, LC3II/I,
[64]
AMPK-α, mTOR, ULK1, PINK1,
Parkin, Cyt C, caspase-3 and
caspase-9

Transgenic C. elegans
PD model NL5901

Inhibits the amyloid formation of α-syn
α-syn and extends the life span of
C. elegans NL5901

[65]

Induces autophagy and promotes α-syn, p62, and LC3II/I
α-syn clearance

[66]

(−)-Epigallocatechin-3- MPTP-induced mice
gallate
Acanthopanax senticosus
Root and rhizome

[63]

Ganoderma lucidum
Extracts

Radix Glycyrrhizae
Isoliquiritigenin and
liquiritin
Tripterygium wilfordii
Triptolide and celastrol MN9D cells

AMPK-α, AMP-activated protein kinase-α; α-syn, α-synuclein; DA, dopamine; DAT, dopamine transporter; DHE, dihydroethidium;
DOPAC, dihydroxyphenylacetic acid; GSSG, glutathione disulfide; HVA, homovanillic acid; JNK, c-Jun N-terminal kinase; LRRK2,
leucine-rich repeat kinase 2; NDUFV2, NADH dehydrogenase ubiquinone flavoprotein 2; Nrf2, nuclear factor erythroid 2-related
factor 2; OX-42, anti-CR3 complement receptor; OXPHOS, oxidative phosphorylation; PINK1, PTEN-induced kinase 1; SDHA,
succinate dehydrogenase complex flavoprotein subunit A; SDHC, succinate dehydrogenase cytochrome b560 subunit; Shh, sonic
hedgehog; ULK1, Unc-51 like autophagy activating kinase 1.

the Bcl-2 family of proteins [68]. The mitochondriamediated apoptosis regulated by the Bcl-2 family
proteins is a major apoptotic pathway in mammalian cells [69]. This would explain why many
TCM herbal remedies and formulations reverse
mitochondrial dysfunction in neurons. Furthermore, astragaloside IV, astragalus polysaccharide,
and astraisoflavan isolated from Radix Astragali
promote neural stem cell (NSC) proliferation and
induce NSC differentiation toward DA neurons
by up-regulating sonic hedgehog (Shh), NYRR1,
and PTX3 expression [58]. This suggests that TCM
is used as an adjuvant therapy in stem cell-based
therapies for neurodegenerative diseases owing
to the necessity of quality control for the neural
progenitor/precursor cells cultured in vitro prior
to clinical usage [70]. Thus, some TCMs can

reduce neuronal apoptosis and promote NSC
differentiation toward neurons.
3.2

Enhanced NTF secretion

NTFs are a series of secreted proteins that exhibit
multiple effects on neural cell functioning, and
their critical roles in the development, survival,
and homeostasis of the central nervous system
have been extensively investigated [71]. Importantly, a broad range of NTFs have been used to
induce neurogenesis in the adult subventricular
zone. Zigova et al. found that the generation and
growth of new neurons were promoted through
the infusion of exogenous brain-derived neurotrophic factor (BDNF) into the lateral ventricle
oftheadult rat brain for 12 days [72]. Moreover,
glial cell line-derived neurotrophic factor (GDNF),
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basic fibroblast growth factor, and neurotrophin-3
have been reported to enhance neurogenesis
in adults [73, 74]. Furthermore, the induction of
neurogenesis, ectopic expression, or continuous
intracerebral infusion of NTFs such as GDNF and
nerve growth factor (NGF) were demonstrated
to increase the survival of neurons following
acute or chronic brain damage, which suggested
a potential application in the treatment of multiple
neurodegenerative diseases [75–77]. In a study,
immunofluorescence imaging, real-time polymerase chain reaction, and western blot analysis
revealed that the Jia-Jian-Di-Huang-Yin-Zi decoction reversed the loss of GDNF-positive cells and
improved GDNF expression in MPTP-lesioned
mice. These effects might be related to the
neuroprotection of DA neurons [19]. In another
study, Kim et al. found that the ginsenosides
Rg5 and Rh3 improved BDNF expression
inscopolamine-induced male Institute of Cancer
Research (ICR) mice, which may be responsible
for alleviating memory deficits [38]. Furthermore,
α-asarone and β-asarone derived from Acorus
tatarinowii have been shown to increase the
expression and secretion of NTFs, such as NGF,
BDNF, and GDNF, in astrocytes [78]. Thus, TCMs
targeting NTFs are potential candidates for use as
new therapeutic agents against neurodegenerative
diseases.
3.3 Regulation of immunomodulation and
neuroinflammation
Neurodegeneration, a hallmark of AD and PD,
is frequently associated with the modulation of
immune and neuroinflammatory responses.
Neuroinflammation refers to the inflammation
occurring in nervous tissue and encompasses
arange of chronic, proinflammatory, and immune
response processes observed in various neurodegenerative diseases. Cumulative data indicate
that inflammation plays an important role in the
development of some neurodegenerative diseases.
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The key innate immune cells in the central nervous
system (CNS) are microglia, astrocytes, and
oligodendrocytes. Increased microglial activation
and astrocytes were found in post-mortem AD
brains, whereas post-mortem PD brains showed
more activated microglia, astrogliosis, and
infiltrated lymphocytes [79, 80]. The expression
of various proinflammatory mediators such as
chemokines and cytokines surrounding plaques
in AD and that in the blood and cerebrospinal
fluid in PD were also found to increase [79, 80].
In addition, various inflammation-associated
substances have caused damage to neurogenesis,
which leads to blockage of the endogenous tissue
repair mechanisms [81]. These findings suggested
that neurodegeneration in AD and PD may be
halted or even reversed via switching of the
immune reaction toward the anti-inflammatory
phenotype [82]. The inflammatory response in
the CNS differs from that found in the rest of the
body and is primarily triggered and maintained
by different polarization of the microglia, which
are macrophages residing in the brain and spinal
cord. Under normal physiological conditions, the
resting state of microglial cells serves to maintain
tissue homeostasis by producing NTFs and
anti-inflammatory mediators [79]. Additional
circulating immune cells could also be recruited
into the CNS by microglial cells via the blood–
brain barrier following activation by a pathogenic
infection or a brain injury. Microglial cells can
also respond to microenvironmental alterations
by acquiring functions of phagocytosis and
mediating neuroinflammation via secretion of
proinflammatory mediators and reactive oxygen
species (ROS) [81]. Consequently, the excessive
activation of proinflammatory phenotypes caused
by microglia can lead to chronic inflammation
and consequently accelerate oxidative stress and
apoptosis induced death oftheneurons. An in
vivo study showed that optimized Yinxieling
formula inhibited the activation of microglia and
Journal of Neurorestoratology
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suppressed the secretion of proinflammatory
cytokines in the MPTP-induced PD mouse models
via down-regulation of the NF-κB signaling
pathway, which protected the DA neurons from
immune-mediated death [21]. Similar effects were
found in an Aβ1–42-induced AD mouse model
treated with an A. oxyphylla–Schisandra chinensis
herbal formulation and an LPS-induced AD mouse
model treated with Nootkatone derived from
A. oxyphylla [29, 31]. Furthermore, in addition
to the inhibition of the NF-κB signaling pathway,
astragaloside IV isolated from A. membranaceus
showed anti-inflammatory and antioxidant properties in the MPTP-induced PD mouse model
through the activation of the Nrf2 pathway [57].
The Nrf2 pathway inhibits activation of the NF-κB
pathway by reducing ROS and preventing IκBα
degradation, whereas the NF-κB pathway antagonizes the Nrf2 pathway by competing for the
binding domain of the Nrf2-antioxidant response
element [83, 84]. Therefore, these pathways negatively regulate each other, and achieving a balance
between them is crucial for redox homeostasis in
healthy cells. Thus, because TCMs target multiple
sites, they could be beneficial for regulating the
crosstalk between these two pathways. Moreover,
G. biloba extract EGb 761 shifted proinflammatory
to anti-inflammatory activation in the AD model
of the P301S Tau mutant transgenic mice [54].
This suggested that EGb 761 may be used in the
monocytes/macrophages cell-based technologies
through the activation of anti-inflammatory
cells in vitro because anti-inflammatory M2
macrophages successfully improved neurological
functioning of patients with severe cerebral palsy
(CP) [85]. The effects of TCM on immunomodulation
and neuroinflammation observed in the in vivo
study are similarto theeffects of different TCMs
demonstrated in vitro, which are summarized in
Table 4. There are far fewer studies on oligodendrocytes than those on astrocytes and microglia.
Oligodendrocytes are key innate immune cells
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in the CNS and also function in response to CNS
injury and diseases by producing poor-quality
myelin or contributing to the inadequate repair
of myelin. Therefore, it is essential to further
explore the immunoregulatory effects of TCMs
on oligodendrocytes.
3.4

Clearance of protein aggregates

Inclusion bodies containing abnormally aggregated
proteins exist widely in various neurodegenerative diseases, which suggested that protein
aggregation played a critical role in the onset of
neurodegeneration [92]. PD is characterized by
the intraneuronal formation of inclusions called
Lewy bodies in the substantia nigra, which mainly
comprise misfolded α-syn protein. Triplication
of the α-syn-encoding SNCA gene has been
implicated in PD [93]. Typically, AD involves
extracellular amyloid plaques predominantly
comprising Aβ peptide and intracellular neurofibrillary tangles, which include the phosphorylated
Tau protein. Amyloid plaque formation is the
main causative factor for AD pathology based
on the theory of amyloid cascade [94]. Therefore,
reducing abnormal protein aggregates or increasing the elimination of aggregated proteins is a
promising therapy for AD and PD. ShaoyaoGancao Tang, a popularly used TCM formulation,
reduces Tau aggregation in the cell model of
tauopathy, thus contributing to the reduction of
neuronal apoptosis through suppression, oxidative
stress, and proinflammatory activities [25].
Furthermore, A. oxyphylla extracts inhibit Aβ
accumulation in both LPS- and Aβ-induced AD
mouse models [28, 30, 31]. Furthermore, treatment
with triptolide derived from T. wilfordii has been
shown to promote α-synclearance by autophagy
induction in the neuronal cells transfected with
A53T mutant [66]. Protein clearance through the
autophagy-lysosomal pathway was also observed
in the AD model of P301S Tau mutant transgenic
mice following the administration of EGb761
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Table 4

The effects of TCMs on neuroinflammation.

Herbs/ingredients

Cell type

Pharmacological functions

Target

Reference

Rhizoma Acori Tatarinowii
α/β-asarone
and oil

Astrocytes

Increases both the synthesis and
NGF, GDNF, BDNF, CREB, ERK, PKA,
release of NTFs and prevents
ROS, ARE, GCLC, GCLM, NQO1, GST,
oxidative stress-induced cell injury and AKT

[78, 86]

Primary rat
microglia

Reduces neuroinflammatory
activation

PGE2, 8-iso-PGF2α, TNF-α, IL-1β, IL-6,
COX-1, COX-2, mPGES-1, cPLA2, p38,
ERK, JNK, and IκBα

[87]

IL-1β, IL-6, iNOS, TGFβ, Arg1, and
MCP-1

[88]

Ginkgo biloba
Extract EGb761

Ganoderma lucidum
Polysaccharides

BV2/ primary
Down-regulates LPS- and
mouse microglia Aβ-induced neuroinflammation

Polygonum multiflorum
CRPE56IGIH

Primary mouse
microglia

Suppresses LPS-induced
neuroinflammatory responses

iNOS, COX-2, HO-1, Nrf2, HO-1, NQO-1, [89]
c-Jun, c-Fos, NF-κB, IκBα, ERK, JNK, p38,
STAT1, STAT3, NO, PGE2, TNF-α, IL-6,
ROS, ARE, AMPK, LKB1, and CaMKII

BV2 microglia

Inhibits neuroinflammationby
NO, iNOS, COX-2, TNF-α, IL-6, ERK,
inhibiting the activation of NLRP3 JNK, p38, IL-1β, NLRP3, ASC, and
inflammasome
caspase-1

[90]

BV2 microglia

Suppresses inflammatory damage

[91]

Psoralea corylifolia
Corylin

Royal jelly
Total royal jelly

iNOS, COX-2, TNF-α, IL-6, HO-1,
MCP-1, IL-1β, IκBα, ERK, JNK, and p38

Arg1, arginase-1; cPLA2, cytosolic phospholipase A2; GCLC, glutamate-cysteine ligase catalytic; GCLM, glutamate-cysteine ligase
modifier subunit; LKB1, liver kinase B1MCP-1, monocyte chemoattractant protein-1; mPGES-1, microsomal prostaglandin E2
synthase; NQO1, NAD(P)H dehydrogenase (quinone)-1; PGE2, prostaglandin E2; PKA, protein kinase A; STAT, signal transducer
and activator of transcription.

extract obtained from G. biloba [54]. Autophagy
is a complex multistep process involved in the
delivery of cellular substrates to lysosomes for
bulk degradation. Autophagy deficiency in
mice is known to cause behavioral dysfunction,
progressive deficits in motor function, and
accumulation of polyubiquitinated cytoplasmic
inclusion bodies in neurons [95, 96]. Therefore,
the autophagy pathway is thought to be an ideal
target for treating neurodegenerative diseases.

4

Conclusion

This review highlights recent findings on the
roles of a range of TCMs or their extracts in

AD and PD treatment. Both AD and PD have
multifactorial pathogenesis involving neuronal
cells and immune cells or other components of
the cellular microenvironment. This explains why
some current drugs that are effective against
a single target are unable to retard disease
progression. To this end, TCMs may be more
suitable because they operate against multiple
targets; therefore, they are receiving increasing
attention for application in the treatment of
neurodegenerative diseases.
Recent studies combining modern neuropharmacology, advanced isolation, and analysis
technologies have been popular in these past
decades and have revealed various mechanisms
Journal of Neurorestoratology
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underlying the effects of TCMs. These mechanisms
include enhancement of neurogenesis, triggering
of NTF secretion, inhibition of neuroinflammation,
and clearance of protein aggregates, all of which
are summarized in this review. Notably, many
studies have focused on individual active ingredients of TCMs. However, the clinical application
of TCMs is always in the form of formulas.
Therefore, randomized controlled trials of TCM
formulas in line with the consolidated standards
of reporting trials are necessary for breakthroughs
in therapeutic strategies against neurodegenerative
diseases.
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